PE investments decline 28% to $1.94 bn in Apr-Jun qtr

In January-March quarter, private equity firms invested $2.43 billion via 109 deals

Press Trust of India New Delhi
Last Updated : Jul 02 2014 | 8:51 PM IST
Private equity (PE) investments in the April-June quarter dropped 28% to $1.94 billion due to various uncertainties including those related to the new companies law, says a report.

During the April-June period of 2014, PE firms invested $1.94 billion across 88 deals as compared to $2.69 billion through 114 transactions in the same period last year, according to a quarterly study by Venture Intelligence.

In January-March quarter, private equity firms invested $2.43 billion via 109 deals.

Also Read

General elections and uncertainties over the new Companies Act led to slide in investments, the report said.

According to the report, e-commerce, pharma companies attracted dominant share of private equity investments in the second quarter of the calender year 2014.

There were four PE investments worth atleast $100 million in April-June quarter of 2014 compared to eight such transactions in the same period last year.

"With national election results out only in the last month of the quarter and the new rules imposed by the New Companies Act delaying a few deal closures, investors squeezed through bets on 'safe sectors' in second quarter of 2014," the report said.

E-commerce leader Flipkart's latest round of investments totalling $210 million led by Russia-based DST Global - was the largest PE investment announced during the quarter. Flipkart, which has been attracting new investors from around the world into India regularly over the last couple of years, has now raised $750 million in total.

The next two largest transactions were in the pharma sector and involved investors who have been operating in India for more than a decade --Temasek and Warburg Pincus.

While Temasek paid a reported $170 million to buyout fellow PE investor ChrysCapital from Intas Pharma, Warburg Pincus committed to invest $150 million in Laurus Labs including by buying out the stake held by previous investor Fidelity Growth Partners India.

Led by these mega deals, the information technology (IT), IT enabled services, healthcare and life sciences segments accounted for 67% of the investment pie during the period, the report showed.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 02 2014 | 7:28 PM IST

Next Story